Evidence map›Paper›PMID 36882406›Full record

ArticleNature communications2023

Optical control of PIEZO1 channels.

Francisco Andrés Peralta, Mélaine Balcon, Adeline Martz, Deniza Biljali, Federico Cevoli, Benoit Arnould, Antoine Taly, Thierry Chataigneau, Thomas Grutter

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Switchable molecular tweezers: design and applications.Beilstein journal of organic chemistry · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Piezo1 in Digestive System Function and Dysfunction.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Francisco Andrés PeraltaÉquipe de Chimie et Neurobiologie Moléculaire, Laboratoire de Conception et Application de Molécules Bioactives (CAMB) UMR 7199, Université de Strasbourg, Centre National de la Recherche Scientifique, Faculté de Pharmacie, 67401, Illkirch, France.ORCID 0000-0002-0727-1706
Mélaine BalconÉquipe de Chimie et Neurobiologie Moléculaire, Laboratoire de Conception et Application de Molécules Bioactives (CAMB) UMR 7199, Université de Strasbourg, Centre National de la Recherche Scientifique, Faculté de Pharmacie, 67401, Illkirch, France.
Adeline MartzÉquipe de Chimie et Neurobiologie Moléculaire, Laboratoire de Conception et Application de Molécules Bioactives (CAMB) UMR 7199, Université de Strasbourg, Centre National de la Recherche Scientifique, Faculté de Pharmacie, 67401, Illkirch, France.
Deniza BiljaliÉquipe de Chimie et Neurobiologie Moléculaire, Laboratoire de Conception et Application de Molécules Bioactives (CAMB) UMR 7199, Université de Strasbourg, Centre National de la Recherche Scientifique, Faculté de Pharmacie, 67401, Illkirch, France.
Federico CevoliÉquipe de Chimie et Neurobiologie Moléculaire, Laboratoire de Conception et Application de Molécules Bioactives (CAMB) UMR 7199, Université de Strasbourg, Centre National de la Recherche Scientifique, Faculté de Pharmacie, 67401, Illkirch, France.
Benoit ArnouldÉquipe de Chimie et Neurobiologie Moléculaire, Laboratoire de Conception et Application de Molécules Bioactives (CAMB) UMR 7199, Université de Strasbourg, Centre National de la Recherche Scientifique, Faculté de Pharmacie, 67401, Illkirch, France.
Antoine TalyLaboratoire de Biochimie Théorique, CNRS, Université Paris Cité, UPR 9080, Paris, France.
Thierry ChataigneauÉquipe de Chimie et Neurobiologie Moléculaire, Laboratoire de Conception et Application de Molécules Bioactives (CAMB) UMR 7199, Université de Strasbourg, Centre National de la Recherche Scientifique, Faculté de Pharmacie, 67401, Illkirch, France.
Thomas GrutterÉquipe de Chimie et Neurobiologie Moléculaire, Laboratoire de Conception et Application de Molécules Bioactives (CAMB) UMR 7199, Université de Strasbourg, Centre National de la Recherche Scientifique, Faculté de Pharmacie, 67401, Illkirch, France. grutter@unistra.fr.ORCID 0000-0002-4351-9203

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PIEZO proteins are unusually large, mechanically-activated trimeric ion channels. The central pore features structural similarities with the pore of other trimeric ion channels, including purinergic P2X receptors, for which optical control of channel gating has been previously achieved with photoswitchable azobenzenes. Extension of these chemical optogenetics methods to mechanically-activated ion channels would provide tools for specific manipulation of pore activity alternative to non-specific mechanical stimulations. Here we report a light-gated mouse PIEZO1 channel, in which an azobenzene-based photoswitch covalently tethered to an engineered cysteine, Y2464C, localized at the extracellular apex of the transmembrane helix 38, rapidly triggers channel gating upon 365-nm-light irradiation. We provide evidence that this light-gated channel recapitulates mechanically-activated PIEZO1 functional properties, and show that light-induced molecular motions are similar to those evoked mechanically. These results push the limits of azobenzene-based methods to unusually large ion channels and provide a simple stimulation means to specifically interrogate PIEZO1 function.

Indexed as

Azo CompoundsCysteineAnimalsIon ChannelsMiceMotionOptogeneticsazobenzeneAzo CompoundsCysteineIon ChannelsPiezo1 protein, mouse

Identifiers

PMID36882406
PMCPMC9992513

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.